potassium nitrate: Clinical Trials

10 trials of potassium nitrate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 10
Phase 11Completed 1

Follow potassium nitrate: new trials by email Literature Review of potassium nitrate trials Research Report on potassium nitrate

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin Hypersensitivity
Potassium Nitrate, Stannous Fluoride - Dentin Hypersensitivity, Dentin Sensitivity
Phase 2CompletedGlaxoSmithKline1232019-05-132020-09-11
The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
Potassium Nitrate, Potassium Chloride - Contrast-induced Nephropathy, Acute Kidney Injury
Phase 2CompletedBarts & The London NHS Trust6402018-11-292022-12-16
Targeting Pulsatile Load to Increase Exercise Capacity and Quality of Life After Aortic Valve Replacement for Severe Aortic Stenosis (PULSE AS)
Potassium Nitrate, Potassium Chloride - Aortic Valve Stenosis
Phase 2CompletedUniversity of Pennsylvania52018-05-012020-06-17
Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF): Dose Response
KNO3, potassium nitrate - Heart Failure
Phase 1 / Phase 2CompletedWashington University School of Medicine422017-10-312025-05-20
Different Concentrations of Potassium Nitrate in In-office Tooth Bleaching Sensitivity
3% potassium nitrate and 0.25% sodium fluoride, 5% potassium nitrate and 2% sodium fluoride - Tooth Sensitivity
Phase 2CompletedUniversidade Federal do Amazonas562016-12-212017-10-27
Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)
Potassium Nitrate (KNO3), Potassium Chloride (KCl) - Heart Failure
Phase 2CompletedUniversity of Pennsylvania842016-08-012023-12-18
Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream
Control toothpaste containing NovaminĀ® technology, Control toothpaste containing 1500 ppm fluoride as MFP, Test toothpaste with nano-HAP (high concentration) - Dentin Sensitivity
Phase 2CompletedThe University of Texas Health Science Center at San Antonio2032015-05-012018-11-16
Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF
KNO3, KCl - Heart Failure, Diastolic Heart Failure
Phase 2CompletedUniversity of Pennsylvania122015-01-012017-10-03
Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity
Potassium nitrate and sodium fluoride, Standard fluoride dentifrice - Dentin Sensitivity
Phase 2CompletedGlaxoSmithKline1912014-09-022018-08-27
Efficacy of Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity
5% Potassium nitrate, 2.5% Potassium nitrate, Sterile water - Dentine Hypersensitivity
Phase 2CompletedGlaxoSmithKline322009-09-012015-01-26

Conditions studied

Dentin Sensitivity (5)  ·  Heart Failure (3)  ·  Acute Coronary Syndrome (1)  ·  Acute Kidney Injury (1)  ·  Aortic Valve Stenosis (1)  ·  Heart Failure, Diastolic (1)

Sponsors

GlaxoSmithKline (3)  ·  University of Pennsylvania (3)  ·  Barts & The London NHS Trust (1)  ·  The University of Texas Health Science Center at San Antonio (1)  ·  Universidade Federal do Amazonas (1)  ·  Washington University School of Medicine (1)

Countries

United States (7)  ·  Canada (1)  ·  United Kingdom (1)

Top investigators

Amrita Ahluwalia, PhD (1)  ·  Andrew R Coggan, PhD (1)  ·  Bennett T Amaechi, BDS, MS, PhD (1)  ·  Julio A Chirinos, MD (1)  ·  Julio A Chirinos, MD, PhD (1)  ·  Julio Chirinos, MD (1)  ·  Leandro M Martins, doctorate (1)  ·  Linda R Peterson, MD (1)  ·  Payman Zamani, MD (1)  ·  Sanjiv Shah, MD (1)  ·  Sujith Kuruvilla, MD (1)

Results publications

PMID 27927683, PMID 30803493, PMID 33764198, PMID 38513060, PMID 39693096

NIH funding

2016 (1)